OKYO Latest Press Releases

-- October 6, 2026 --

OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain Globe Newswire 7:00 AM

-- September 29, 2026 --

OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences Globe Newswire 7:00 AM

-- September 9, 2026 --

OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026 Globe Newswire 7:00 AM

-- September 8, 2026 --

OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference Globe Newswire 7:00 AM

-- July 28, 2026 --

OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer Globe Newswire 7:00 AM

-- July 27, 2026 --

OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026 Globe Newswire 7:00 AM

-- July 23, 2026 --

OKYO Pharma Announces Purchase of Shares by Director Globe Newswire 12:00 PM

OKYO Pharma Announces Purchase of Shares by Chief Executive Officer Globe Newswire 7:00 AM

-- July 22, 2026 --

OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director Globe Newswire 10:00 AM

OKYO Pharma Announces Purchase of Shares by Chief Medical Officer Globe Newswire 7:00 AM

-- July 21, 2026 --

OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference Globe Newswire 9:00 AM

OKYO Pharma Announces Purchase of Shares by Chairman Globe Newswire 7:00 AM

-- July 20, 2026 --

OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans Globe Newswire 7:00 AM

-- July 8, 2026 --

OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain Globe Newswire 7:00 AM

-- July 7, 2026 --

OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes